Skip to main content
. 2020 Aug;9(4):1247–1257. doi: 10.21037/tlcr-19-530

Figure 4.

Figure 4

ROC curve analysis for the discriminatory power of salivary miRNA biomarkers. In MPE patients versus HCs, hsa-miR-4484 showed an AUC of 0.768, with a sensitivity of 74.1% and a specificity of 74.4%. The AUC for hsa-miR-3663-3p was 0.666, with a sensitivity of 50.4% and a specificity of 79.6% (A). The predictive power of combined salivary hsa-miR-4484 and hsa-miR-3663-3p also determined by ROC curve analysis (B). We obtained a sensitivity of 82.2% and a specificity of 74.1%. The calculated area under the ROC curve was 0.802.